PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in NSCLC

被引：0
|
作者：
Liu, J. [1 ]
Zhou, H. [1 ]
Zhang, Y. [1 ]
Huang, Y. [1 ]
Yang, Y. [1 ]
Fang, W. [1 ]
Zhang, L. [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
基金：
国家重点研发计划;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
320O
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
    Goodman, Aaron M.
    Piccioni, David
    Kato, Shumei
    Boichard, Amelie
    Wang, Huan-You
    Frampton, Garrett
    Lippman, Scott M.
    Connelly, Caitlin
    Fabrizio, David
    Miller, Vincent
    Sicklick, Jason K.
    Kurzrock, Razelle
    JAMA ONCOLOGY, 2018, 4 (09) : 1237 - 1244
  • [22] COMBINATION IMMUNE CHECKPOINT BLOCKADE PROMISING IN OPERABLE NSCLC
    Cascone, T.
    William, W. N., Jr.
    Weissferdt, A.
    Leung, C. H.
    Lin, H. Y.
    Pataer, A.
    CANCER DISCOVERY, 2021, 11 (05) : 1003 - 1003
  • [23] Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better
    Zheng, Ming
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [24] Biomarkers for Response to Immune Checkpoint Blockade
    Ganesan, Shridar
    Mehnert, Janice
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 2020, 4 : 331 - 351
  • [25] Hallmarks of response to immune checkpoint blockade
    Alexandria P Cogdill
    Miles C Andrews
    Jennifer A Wargo
    British Journal of Cancer, 2017, 117 : 1 - 7
  • [26] Hallmarks of response to immune checkpoint blockade
    Cogdill, Alexandria P.
    Andrews, Miles C.
    Wargo, Jennifer A.
    BRITISH JOURNAL OF CANCER, 2017, 117 (01) : 1 - 7
  • [27] Comprehensive analyses of PBRM1 in multiple cancer types and its association with clinical response to immunotherapy and immune infiltrates
    Yang, Qiuan
    Shen, Rong
    Xu, Hanlin
    Shi, Xiaoliang
    Xu, Lili
    Zhang, Lin
    Fan, Xinglong
    Jin, Xiangfeng
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [28] Inactivating frameshift mutation of PBRM1, a putative tumour suppressor gene, in colorectal cancers
    Jo, Yun Sol
    Kim, Min Sung
    Kim, Nam Jin
    Kim, Sug Hyung
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (05) : 639 - 640
  • [29] Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer
    Cho, Namjoon
    Kim, Seung-Yeon
    Lee, Sung-Gwon
    Park, Chungoo
    Choi, Sunkyung
    Kim, Eun-Mi
    Kim, Kee K.
    EMBO JOURNAL, 2024, : 5421 - 5444
  • [30] EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
    Hastings, K.
    Yu, H. A.
    Wei, W.
    Sanchez-Vega, F.
    DeVeaux, M.
    Choi, J.
    Rizvi, H.
    Lisberg, A.
    Truini, A.
    Lydon, C. A.
    Liu, Z.
    Henick, B. S.
    Wurtz, A.
    Cai, G.
    Plodkowski, A. J.
    Long, N. M.
    Halpenny, D. F.
    Killam, J.
    Oliva, I
    Schultz, N.
    Riely, G. J.
    Arcila, M. E.
    Ladanyi, M.
    Zelterman, D.
    Herbst, R. S.
    Goldberg, S. B.
    Awad, M. M.
    Garon, E. B.
    Gettinger, S.
    Hellmann, M. D.
    Politi, K.
    ANNALS OF ONCOLOGY, 2019, 30 (08) : 1311 - 1320
12345